Page last updated: 2024-11-03

pyrimethamine and Leukoencephalopathy, Progressive Multifocal

pyrimethamine has been researched along with Leukoencephalopathy, Progressive Multifocal in 1 studies

Maloprim: contains above 2 cpds

Leukoencephalopathy, Progressive Multifocal: An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Devivo, DC1
Malas, D1
Nelson, JS1
Land, VJ1

Other Studies

1 other study available for pyrimethamine and Leukoencephalopathy, Progressive Multifocal

ArticleYear
Leukoencephalopathy in childhood leukemia.
    Neurology, 1977, Volume: 27, Issue:7

    Topics: Adolescent; Cerebral Cortex; Gliosis; Humans; Leukemia, Lymphoid; Leukoencephalopathy, Progressive M

1977